MiNK Therapeutics, Inc.·4

Sep 6, 5:04 PM ET

Behner Peter 4

4 · MiNK Therapeutics, Inc. · Filed Sep 6, 2023

Insider Transaction Report

Form 4
Period: 2023-09-01
Behner Peter
Director
Transactions
  • Award

    Common Stock

    2023-09-01$1.46/sh+10,531$15,37544,058 total
Footnotes (2)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
  • [F2]In Table 1 of the Form 4 filed on June 2, 2023, the amount of securities acquired and price (column 4) and amount of securities beneficially owned following reported transaction (column 5) were erroneously reported. On June 1, 2023, 8,542 RSUs were acquired at a price of $1.80 each, resulting in a total amount of securities beneficially owned following the reported transaction of 33,527 instead of 33,721 as erroneously reported.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4